XML 18 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Condensed Statements Of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Apr. 01, 2017
Apr. 02, 2016
CASH FLOWS FROM OPERATING ACTIVITIES    
Net earnings attributable to Moog and noncontrolling interest $ 61,720 $ 57,067
Adjustments to reconcile net earnings to net cash provided (used) by operating activities:    
Depreciation 35,372 38,554
Amortization 9,325 11,428
Deferred income taxes 423 2,292
Equity-based compensation expense 3,154 1,919
Other 15,481 5,991
Changes in assets and liabilities providing (using) cash:    
Receivables (20,989) (5,606)
Inventories 14,327 (5,330)
Accounts payable 13,536 (13,439)
Customer advances 8,869 10,888
Accrued expenses 449 (5,802)
Accrued income taxes (858) 2,552
Net pension and post retirement liabilities (9,413) (13,171)
Other assets and liabilities (9,690) (8,920)
Net cash provided by operating activities 121,706 78,423
CASH FLOWS FROM INVESTING ACTIVITIES    
Acquisitions of businesses, net of cash acquired 0 (11,016)
Purchase of property, plant and equipment (30,210) (27,685)
Other investing transactions (928) 1,058
Net cash (used) by investing activities (31,138) (37,643)
CASH FLOWS FROM FINANCING ACTIVITIES    
Net short-term repayments (1,280) 0
Proceeds from revolving lines of credit 94,145 210,320
Payments on revolving lines of credit (143,700) (182,455)
Payments on long-term debt (97) (9,660)
Proceeds from sale of treasury stock 2,135 2,229
Purchase of outstanding shares for treasury (5,305) (25,156)
Proceeds from sale of stock held by SECT 867 2,897
Purchase of stock held by SECT (7,038) (1,515)
Purchase of stock held by SERP Trust 0 (2,300)
Excess tax benefits from equity-based payment arrangements 0 471
Other financing transactions (1,656) 0
Net cash (used) by financing activities (61,929) (5,169)
Effect of exchange rate changes on cash (11,278) 2,858
Increase in cash, cash equivalents and restricted cash 17,361 38,469
Cash, cash equivalents and restricted cash at beginning of period 325,128 309,853
Cash, cash equivalents and restricted cash at end of period $ 342,489 $ 348,322